These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 9057255)
41. Extent and duration of virulent virus excretion upon challenge of pigs vaccinated with different glycoprotein-deleted Aujeszky's disease vaccines. Pensaert MB; De Smet K; De Waele K Vet Microbiol; 1990 Apr; 22(2-3):107-17. PubMed ID: 2162094 [TBL] [Abstract][Full Text] [Related]
42. Effect of maternally acquired Aujeszky's disease (pseudorabies) virus-specific antibody in pigs on establishment of latency and seroconversion to differential glycoproteins after low dose challenge. McCaw MB; Osorio FA; Wheeler J; Xu J; Erickson GA Vet Microbiol; 1997 Apr; 55(1-4):91-8. PubMed ID: 9220600 [TBL] [Abstract][Full Text] [Related]
43. Dose-dependent pathogenicity of a pseudorabies virus variant in pigs inoculated via intranasal route. Wang Y; Xia SL; Lei JL; Cong X; Xiang GT; Luo Y; Sun Y; Qiu HJ Vet Immunol Immunopathol; 2015 Dec; 168(3-4):147-52. PubMed ID: 26672913 [TBL] [Abstract][Full Text] [Related]
44. A single dose glycoprotein D-based subunit vaccine against pseudorabies virus infection. Zhang T; Liu Y; Chen Y; Wang A; Feng H; Wei Q; Zhou E; Zhang G Vaccine; 2020 Sep; 38(39):6153-6161. PubMed ID: 32741670 [TBL] [Abstract][Full Text] [Related]
45. A live, attenuated pseudorabies virus strain JS-2012 deleted for gE/gI protects against both classical and emerging strains. Tong W; Li G; Liang C; Liu F; Tian Q; Cao Y; Li L; Zheng X; Zheng H; Tong G Antiviral Res; 2016 Jun; 130():110-7. PubMed ID: 26946112 [TBL] [Abstract][Full Text] [Related]
46. Commercial vaccine against pseudorabies virus: A hidden health risk for dogs. Lin W; Shao Y; Tan C; Shen Y; Zhang X; Xiao J; Wu Y; He L; Shao G; Han M; Wang H; Ma J; Xie Q Vet Microbiol; 2019 Jun; 233():102-112. PubMed ID: 31176394 [TBL] [Abstract][Full Text] [Related]
47. A novel gE-deleted pseudorabies virus (PRV) provides rapid and complete protection from lethal challenge with the PRV variant emerging in Bartha-K61-vaccinated swine population in China. Wang CH; Yuan J; Qin HY; Luo Y; Cong X; Li Y; Chen J; Li S; Sun Y; Qiu HJ Vaccine; 2014 Jun; 32(27):3379-85. PubMed ID: 24793946 [TBL] [Abstract][Full Text] [Related]
48. Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs. van Rooij EM; de Bruin MG; de Visser YE; Middel WG; Boersma WJ; Bianchi AT Vet Immunol Immunopathol; 2004 May; 99(1-2):113-25. PubMed ID: 15113659 [TBL] [Abstract][Full Text] [Related]
50. A noval strategy of deletion in PK gene for construction of a vaccine candidate with exellent safety and complete protection efficiency against high virulent Chinese pseudorabies virus variant. Xu M; Zhang C; Liu Y; Chen S; Zheng Y; Wang Z; Cao R; Wang J Virus Res; 2022 May; 313():198740. PubMed ID: 35271886 [TBL] [Abstract][Full Text] [Related]
51. Prevalence of antibodies of field pseudorabies virus in pigs of herd vaccinated with live vaccine. Asai T; Tajima M; Watanabe H; Shibata I J Vet Med Sci; 1998 Mar; 60(3):399-400. PubMed ID: 9560796 [TBL] [Abstract][Full Text] [Related]
52. Development of active immunity in newborn pigs with colostral antibodies by vaccination with gIII-deleted PRV. Kit S; Kit M; McConnell S; Lawhorn B Acta Vet Hung; 1994; 42(2-3):319-30. PubMed ID: 7810426 [TBL] [Abstract][Full Text] [Related]
53. Safety and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant expressing the E2 protein of classical swine fever virus in pigs. Lei JL; Xia SL; Wang Y; Du M; Xiang GT; Cong X; Luo Y; Li LF; Zhang L; Yu J; Hu Y; Qiu HJ; Sun Y Immunol Lett; 2016 Jun; 174():63-71. PubMed ID: 27113530 [TBL] [Abstract][Full Text] [Related]
54. Detection of pseudorabies virus infection in subunit-vaccinated and nonvaccinated pigs using a nucleocapsid-based enzyme-linked immunosorbent assay. McGinley MJ; Todd DL; Hill HT; Platt KB J Vet Diagn Invest; 1992 Apr; 4(2):164-9. PubMed ID: 1319749 [TBL] [Abstract][Full Text] [Related]
55. Evaluation in swine of a subunit vaccine against pseudorabies. Maes RK; Schutz JC Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337 [TBL] [Abstract][Full Text] [Related]
56. Construction of a triple gene-deleted Chinese Pseudorabies virus variant and its efficacy study as a vaccine candidate on suckling piglets. Zhang C; Guo L; Jia X; Wang T; Wang J; Sun Z; Wang L; Li X; Tan F; Tian K Vaccine; 2015 May; 33(21):2432-7. PubMed ID: 25865469 [TBL] [Abstract][Full Text] [Related]
57. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus. van Oirschot JT; Gielkens AL Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645 [TBL] [Abstract][Full Text] [Related]
58. Development of a blocking immunoperoxidase monolayer assay for differentiation between pseudorabies virus-infected and vaccinated animalss. Wang YB; Li YH; Li QM; Xie WT; Guo CL; Guo JQ; Deng RG; Zhang GP Pol J Vet Sci; 2019 Dec; 22(4):717-723. PubMed ID: 31867929 [TBL] [Abstract][Full Text] [Related]
59. Immunohistological characterization of the local cellular response directed against pseudorabies virus in pigs. Bouma A; Zwart RJ; De Bruin MG; De Jong MC; Kimman TG; Bianchi AT Vet Microbiol; 1997 Nov; 58(2-4):145-54. PubMed ID: 9453126 [TBL] [Abstract][Full Text] [Related]
60. Lack of serum antibodies against glycoprotein E in pseudorabies virus-immune pigs infected with wild-type virus. Jacobs L; Kimman TG; Bianchi A Am J Vet Res; 1996 Nov; 57(11):1525-8. PubMed ID: 8915423 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]